CX3CL1 at the crossroad of EGF signals: Relevance for the progression of ERBB2+ breast carcinoma.
Oncoimmunology
; 2(9): e25669, 2013 Sep 01.
Article
em En
| MEDLINE
| ID: mdl-24319638
ABSTRACT
Inflammatory mediators can play a dual role in oncogenesis and tumor progression. CX3CL1, a chemokine previously implicated in natural killer cell- and CD8+ T cell-mediated antitumor immune responses, has now been identified as a promoter of ERBB2-expressing breast carcinomas as it cross-activates members of the epidermal growth factor receptor family.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
Oncoimmunology
Ano de publicação:
2013
Tipo de documento:
Article